News | October 14, 2022
Cytel to acquire SDS Life Science and SDS MedteQ
The move will add new global talent to Cytel’s Strategic Consulting group
The move will add new global talent to Cytel’s Strategic Consulting group
The Coalition for Epidemic Preparedness Innovations (CEPI) has recently partnered with the consortium of India-based Bharat Biotech, University of Sydney and ExcellGene to develop “variantproof” COVID-19 vaccine.
Thermo Fisher is working closely with large pharmaceutical businesses to develop companion diagnostics in multiple areas such as heart disease, neurosciences and infectious diseases.
The MoU will enable both countries to promote research collaboration and building capacities in the field of the Indian Ayurvedic system of traditional medicines
This clinical study will inform operational logistics and use of AV7909 should an anthrax emergency occur.
This win is on the back of a prestigious order from Reliance Life Sciences
Brivaracetam is indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
The agreement provides for acquisition of 13,50,000 equity shares of Rs. 100 each constituting 50% of the total equity share capital
The inspection concluded with no observation (FDA-483) issued.
This acquisition will accelerate Medcare's plans to emerge as an international hub for health, beauty, and wellness adding to its existing network of 4 hospitals and over 20 medical centres in the UAE.
Subscribe To Our Newsletter & Stay Updated
